patented prescription drugs

Printer-friendly version
New regulations will ultimately deprive Canadians of new medicines

Drug developers are more likely to invest in research and development if prices for their medicines are high.

Printer-friendly version
Consent—a fundamental tenet of democracy

Rather than write and debate legislation, politicians increasingly leave the difficult work of legislating to bureaucrats.

Printer-friendly version
Increasing barriers for drug manufacturers may ultimately hurt patients

Ottawa’s changes may delay the launch of new innovative medications in Canada.